Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Clinical trial NCT04373265 · COMPLETED
Trial details
- NCT number
- NCT04373265
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-10-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.